Literature DB >> 18687905

Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance.

Rajesh K Aneja1, Allan Tsung, Hanna Sjodin, Julia V Gefter, Russell L Delude, Timothy R Billiar, Mitchell P Fink.   

Abstract

High mobility group box protein 1 (HMGB1) modulates the innate immune response when present in the extracellular compartment. Receptors for HMGB1 include TLR4, TLR2, and the receptor for advanced glycation end products (RAGE). We tested the hypothesis that extracellular HMGB1 can induce LPS tolerance. HMGB1 dose-response experiments were performed on IFN-gamma-differentiated human monocyte-like THP-1 cells. Treatment with 1 microg/ml HMGB1 18 h before exposure to LPS (1 microg/ml) decreased TNF release, NF-kappaB nuclear DNA-binding activity, phosphorylation, and degradation of IkappaBalpha. Preconditioning with HMGB1 alone and HMGB1 in the presence of polymyxin B decreased LPS-mediated, NF-kappaB-dependent luciferase reporter gene expression. The specificity of HMGB1 in tolerance induction was supported further by showing that boiled HMGB1 failed to induce tolerance, and antibodies against HMGB1 blocked the induction of LPS tolerance. Bone marrow-derived macrophages obtained from C57Bl/6 wild-type mice became LPS-tolerant following HMGB1 exposure ex vivo, but macrophages derived from RAGE-deficient mice failed to develop tolerance and responded normally to LPS. Mice preconditioned with HMGB1 (20 microg) 1 h before LPS injection (10 mg/kg) had lower circulating TNF compared with control mice preconditioned with saline vehicle. Similarly, decreased nuclear DNA binding of hepatic NF-kappaB was observed in mice preconditioned with HMGB1. Taken together, these results suggest that extracellular HMGB1 induces LPS tolerance, and the RAGE receptor is required for this induction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687905      PMCID: PMC2567896          DOI: 10.1189/jlb.0108030

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  42 in total

Review 1.  HMGB1 as a late mediator of lethal systemic inflammation.

Authors:  H Wang; H Yang; C J Czura; A E Sama; K J Tracey
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

2.  Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.

Authors:  J C Mathison; G D Virca; E Wolfson; P S Tobias; K Glaser; R J Ulevitch
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock.

Authors:  M Ombrellino; H Wang; M S Ajemian; A Talhouk; L A Scher; S G Friedman; K J Tracey
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

4.  The extracellular release of HMGB1 during apoptotic cell death.

Authors:  Charles W Bell; Weiwen Jiang; Charles F Reich; David S Pisetsky
Journal:  Am J Physiol Cell Physiol       Date:  2006-07-19       Impact factor: 4.249

5.  Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells.

Authors:  Rajesh Aneja; Kelli Odoms; Katherine Dunsmore; Thomas P Shanley; Hector R Wong
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

6.  RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages.

Authors:  R Kokkola; A Andersson; G Mullins; T Ostberg; C-J Treutiger; B Arnold; P Nawroth; U Andersson; R A Harris; H E Harris
Journal:  Scand J Immunol       Date:  2005-01       Impact factor: 3.487

Review 7.  Extracellular role of HMGB1 in inflammation and sepsis.

Authors:  H Wang; H Yang; K J Tracey
Journal:  J Intern Med       Date:  2004-03       Impact factor: 8.989

Review 8.  Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA.

Authors:  P Prendergast; S A Oñate; K Christensen; D P Edwards
Journal:  J Steroid Biochem Mol Biol       Date:  1994-01       Impact factor: 4.292

9.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  Role of HMGB1 in apoptosis-mediated sepsis lethality.

Authors:  Shixin Qin; Haichao Wang; Renqi Yuan; Hui Li; Mahendar Ochani; Kanta Ochani; Mauricio Rosas-Ballina; Chris J Czura; Jared M Huston; Ed Miller; Xinchun Lin; Barbara Sherry; Anjali Kumar; Greg Larosa; Walter Newman; Kevin J Tracey; Huan Yang
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  29 in total

1.  Advanced glycation endproducts induce self- and cross-tolerance in monocytes.

Authors:  Florian Uhle; Sebastian Weiterer; Benedikt Hermann Siegler; Thorsten Brenner; Christoph Lichtenstern; Markus Alexander Weigand
Journal:  Inflamm Res       Date:  2017-06-28       Impact factor: 4.575

2.  Aged Human Stored Red Blood Cell Supernatant Inhibits Macrophage Phagocytosis in an HMGB1 Dependent Manner After Trauma in a Murine Model.

Authors:  Kent R Zettel; Mitchell Dyer; Jay S Raval; Xubo Wu; John R Klune; Andres Gutierrez; Darrell J Triulzi; Timothy R Billiar; Matthew D Neal
Journal:  Shock       Date:  2017-02       Impact factor: 3.454

3.  Endotoxin tolerance alleviates experimental acute liver failure via inhibition of high mobility group box 1.

Authors:  Nai-Bin Yang; Shun-Lan Ni; Shan-Shan Li; Sai-Nan Zhang; Dan-Ping Hu; Ming-Qin Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

4.  Differential regulation of the transcriptomic and secretomic landscape of sensor and effector functions of human airway epithelial cells.

Authors:  Roland Lehmann; Mario M Müller; Tilman E Klassert; Dominik Driesch; Magdalena Stock; Anina Heinrich; Theresia Conrad; Christoph Moore; Uta K Schier; Reinhard Guthke; Hortense Slevogt
Journal:  Mucosal Immunol       Date:  2018-01-03       Impact factor: 7.313

5.  Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis.

Authors:  Weiqiang Chen; Xiaoling Qiang; Yongjun Wang; Shu Zhu; Jianhua Li; Ariella Babaev; Huan Yang; Jonathan Gong; Lance Becker; Ping Wang; Kevin J Tracey; Haichao Wang
Journal:  Sci Transl Med       Date:  2020-04-15       Impact factor: 17.956

Review 6.  Targeting HMGB1 in the treatment of sepsis.

Authors:  Haichao Wang; Mary F Ward; Andrew E Sama
Journal:  Expert Opin Ther Targets       Date:  2014-01-06       Impact factor: 6.902

7.  Damage- and pathogen-associated molecular patterns play differential roles in late mortality after critical illness.

Authors:  John Eppensteiner; Jean Kwun; Uwe Scheuermann; Andrew Barbas; Alexander T Limkakeng; Maggie Kuchibhatla; Eric A Elster; Allan D Kirk; Jaewoo Lee
Journal:  JCI Insight       Date:  2019-08-22

Review 8.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

9.  Synergy between 15-lipoxygenase and secreted PLA2 promotes inflammation by formation of TLR4 agonists from extracellular vesicles.

Authors:  Van Thai Ha; Duško Lainšček; Bernd Gesslbauer; Eva Jarc-Jovičić; Tuulia Hyötyläinen; Nejc Ilc; Katja Lakota; Matija Tomšič; Fons A J van de Loo; Valery Bochkov; Toni Petan; Roman Jerala; Mateja Manček-Keber
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-24       Impact factor: 11.205

10.  Myeloid skewing in murine autoimmune arthritis occurs in hematopoietic stem and primitive progenitor cells.

Authors:  Kwadwo A Oduro; Fang Liu; Qing Tan; Chan-Kyu Kim; Olga Lubman; Daved Fremont; Jason C Mills; Kyunghee Choi
Journal:  Blood       Date:  2012-07-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.